American Society of Hypertension

The American Society of Hypertension (abbreviated ASH) was an American non-profit professional society dedicated to advancing research on hypertension and related cardiovascular diseases.

History

The ASH was founded in 1985 by 17 scientists and physicians. ^[1] In 2005, the ASH cut ties with the American Journal of Hypertension over a dispute over control of content published in the Journal. ^{[2] [3]} In 2006, the society became the center of a dispute over the appropriate role of pharmaceutical industry in medical research. The dispute prompted several members of an ASH group convened to write a new definition of high blood pressure to resign from the group; those resigning included former ASH president Michael H. Alderman. ^[4] In 2017, the society dissolved and merged with the American Heart Association. ^[5] The Journal of the American Society of Hypertension , which was originally the official journal of the ASH, is now affiliated with the AHA. ^[6]

References

1. "American Society of Hypertension". NORD (National Organization for Rare Disorders). Retrieved 2018-09-25.
2. ALDERMAN, M; BANES, J; BLUMENFELD, J; GAVRAS, H; KURTZ, T; LARAGH, J; STEINER, S (July 2005). "The American Journal of Hypertension Withdraws from Its Affiliation with the American Society of Hypertension. A Report to Our Readers". American Journal of Hypertension. 18 (7): 893. doi: 10.1016/j.amjhyper.2005.06.003 . ISSN   0895-7061.
3. Winslow, Ron (2005-07-29). "High Blood Pressure:Doctors Sever Ties With Medical Journal". The Wall Street Journal. Retrieved 2018-09-25.
4. Saul, Stephanie (2006-05-20). "Unease on Industry's Role in Hypertension Debate". The New York Times. Retrieved 2018-09-25.
5. "American Society of Hypertension and American Heart Association to Join Forces to Give a Voice to America's "Silent Killer"". www.prnewswire.com (Press release). 2017-07-11. Retrieved 2018-09-25.
6. "Homepage". Journal of the American Society of Hypertension Website. Retrieved 2018-09-25.